2005
DOI: 10.1097/01.aco.0000174957.97759.f6
|View full text |Cite
|
Sign up to set email alerts
|

Xenon: from stranger to guardian

Abstract: Further clinical trials are required to evaluate the role that xenon can play in the perioperative period.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
19
0
1

Year Published

2010
2010
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(20 citation statements)
references
References 60 publications
0
19
0
1
Order By: Relevance
“…Xenon exerts a potent analgesic action due to NMDA receptor inhibition [25] which may explain the lower overall remifentanil consumption during surgery; however, wash in and wash out of xenon are very fast [9, 13], and NMDA receptor blocking ability may not explain an effect on pain pathways up to 72 hours. Nowadays the evidence is that xenon is able to modulate long-term pathways [12, 14, 22] which are considered the end effectors producing the long-term organoprotective effects of the gas.…”
Section: Discussionmentioning
confidence: 99%
“…Xenon exerts a potent analgesic action due to NMDA receptor inhibition [25] which may explain the lower overall remifentanil consumption during surgery; however, wash in and wash out of xenon are very fast [9, 13], and NMDA receptor blocking ability may not explain an effect on pain pathways up to 72 hours. Nowadays the evidence is that xenon is able to modulate long-term pathways [12, 14, 22] which are considered the end effectors producing the long-term organoprotective effects of the gas.…”
Section: Discussionmentioning
confidence: 99%
“…In recent years several clinical trials have been published that characterize the anaesthetic properties as well as the other potential properties of Xenon [1-4]. Following the licensing of Xenon in 12 European countries in 2007 after Germany was first in 2005 there is increasing interest in gaining a better understanding of the underlying scientific opportunities that Xenon offers as well as the role that Xenon can play in anaesthesia in the future.…”
Section: Introductionmentioning
confidence: 99%
“…Cullen successfully performed general anaesthesia with xenon for the first time in 1951[7]. Xenon comes very close to being the ideal anaesthetic [8-12]. Its unique properties include a rapid onset and offset of action [13] and a recovery index with good arousal quality [14].…”
Section: Discussionmentioning
confidence: 99%